These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3925835)

  • 1. High-dose human menopausal gonadotropin therapy for successful ovulation induction for in vitro fertilization in perimenopausal women.
    Friberg J; Gleicher N
    Ann N Y Acad Sci; 1985; 442():168-77. PubMed ID: 3925835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma hormones in human gonadotropin induced ovulation.
    Wu CH
    Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different follicle-stimulating hormone and luteinizing hormone ratios for ovulation induction during in vitro fertilization.
    Tepper R; Tadir Y; Kaplan-Kraicer R; Amit S; Pinkas H; Ovadia J
    Int J Fertil; 1992; 37(6):335-8. PubMed ID: 1360452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicle-stimulating hormone is the main determinant of follicular recruitment and development in ovulation induction with human menopausal gonadotropin.
    Vermesh M; Kletzky OA
    Am J Obstet Gynecol; 1987 Dec; 157(6):1397-402. PubMed ID: 3122575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro fertilization and embryo transfer: an individualized approach to ovulation induction.
    Taymor ML; Seibel MM; Oskowitz SP; Smith DM; Lee G
    J In Vitro Fert Embryo Transf; 1985 Sep; 2(3):162-5. PubMed ID: 3932569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful pregnancies in patients with estrogenic anovulation after low-dose human chorionic gonadotropin therapy alone following hMG for controlled ovarian hyperstimulation.
    Lee KL; Couchman GM; Walmer DK
    J Assist Reprod Genet; 2005 Jan; 22(1):37-40. PubMed ID: 15807221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
    Dahan MH; Agdi M; Shehata F; Son W; Tan SL
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The empty follicle syndrome: a pharmaceutical industry syndrome.
    Zegers-Hochschild F; Fernández E; Mackenna A; Fabres C; Altieri E; Lopez T
    Hum Reprod; 1995 Sep; 10(9):2262-5. PubMed ID: 8530648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study.
    Felberbaum RE; Albano C; Ludwig M; Riethmüller-Winzen H; Grigat M; Devroey P; Diedrich K
    Hum Reprod; 2000 May; 15(5):1015-20. PubMed ID: 10783344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum luteinizing hormone during ovulation induction with human menopausal gonadotropin for in vitro fertilization in normally menstruating women.
    Ferraretti AP; Garcia JE; Acosta AA; Jones GS
    Fertil Steril; 1983 Dec; 40(6):742-7. PubMed ID: 6418573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome from consecutive in-vitro fertilization/intracytoplasmic sperm injection attempts in the final group treated with urinary gonadotrophins and the first group treated with recombinant follicle stimulating hormone.
    Jacob S; Drudy L; Conroy R; Harrison RF
    Hum Reprod; 1998 Jul; 13(7):1783-7. PubMed ID: 9740423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of pure follicle-stimulating hormone for ovulation induction in normal ovulatory women in an in vitro fertilization program.
    Russell JB; Polan ML; DeCherney AH
    Fertil Steril; 1986 Jun; 45(6):829-33. PubMed ID: 2940122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite responses to the addition of leuprolide acetate to human menopausal gonadotropin therapy in two perimenopausal women.
    Check JH; Adelson HG
    Int J Fertil; 1990; 35(6):343-6. PubMed ID: 1981209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of follicle stimulating hormone versus human menopausal gonadotrophin in in-vitro fertilization.
    Daya S; Gunby J; Hughes EG; Collins JA; Sagle MA
    Hum Reprod; 1995 Jun; 10(6):1392-6. PubMed ID: 7593503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous luteinizing hormone surge during superovulation induction with sequential use of clomiphene citrate and pulsatile human menopausal gonadotropin.
    Messinis IE; Templeton A; Baird DT
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1076-80. PubMed ID: 3932447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovulation induction for assisted reproduction.
    Scott RT; Rosenwaks Z
    J Reprod Med; 1989 Jan; 34(1 Suppl):108-14. PubMed ID: 2497245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
    Venturoli S; Paradisi R; Fabbri R; Porcu E; Orsini LF; Flamigni C
    Int J Fertil; 1987; 32(1):66-70. PubMed ID: 2880819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal serum pituitary hormone levels and outcome of in vitro fertilization utilizing a flare nasal gonadotropin releasing hormone agonist and fixed low-dose follicle-stimulating hormone/human menopausal gonadotropin regimen.
    Chan YF; Ho PC; So WW; Yeung WS
    J Assist Reprod Genet; 1993 May; 10(4):251-4. PubMed ID: 8130428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.